P/B
2,2
Inspire Medical Systems
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
$1.9B
Market Cap • 11/6/2026
2007
(19 years)
Founded
2018
(8 years ago)
IPO
NYSE
Listing Exchange
United States
Country
Valuation
P/S
2,1
P/EBITDA
53,8
P/OCF
13,7
P/FCF
18,9
P/E
18,6
BVPS
28,5
EPS
3,5
Market Cap
Market Cap
1,9B
EV
1,6B
EV/Revenue
1,8
EV/EBITDA
45,1
EV/EBIT
98,6
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
2,4%
Total Yield
2,4%
Payout
0%
Retained Earnings
-181,9M
Profitability
Gross Margin
86,2%
EBITDA Margin
3,9%
EBIT Margin
1,8%
Net Margin
11,4%
D&A/EBITDA
0%
R&D/Revenue
11,1%
Capex/Revenue
4,2%
Capex/D&A
198,6%
Capex/OCF
27,5%
SBC/OCF
86,6%
% PPE
11,3%
% Goodwill
0%
ROE
13,5%
ROIC
3,2%
Growth
CAGR Revenue 5Y
34,4%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
6,4
Quick Ratio
3,4
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!